Aggressive surgical resection following neoadjuvant imatinib therapy for advanced duodenal tumor with hepatic metastasis

Aggressive surgical resection following neoadjuvant imatinib therapy for advanced duodenal tumor with hepatic metastasis

Duodenal gastrointestinal stromal tumors (GISTs) are rare tumors which constitute < 5% of all cases of GIST. The treatment of locally advanced/inoperable and metastatic GIST is primarily tyrosine kinase inhibitor therapy (TKI), i.e., imatinib mesylate. In some patients, initial TKI therapy may re...

Full description

Bibliographic Details
Main Authors: Varun Madaan, Rigved Gupta, G K Adithya, Satya Prakash Jindal, Deepak Govil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Apollo Medicine
Subjects:
duodenal gastrointestinal stromal tumor
imatinib
locally advanced gastrointestinal stromal tumor
Online Access:http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2019;volume=16;issue=1;spage=33;epage=35;aulast=Madaan

Internet

http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2019;volume=16;issue=1;spage=33;epage=35;aulast=Madaan

Similar Items